Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • Topics
  • Slideshows
  • Videos
  • Quizzes
  • Blogs
  • Conferences
  • Classifieds
  • All Content
  • Contribute
MJH Life Sciences

SUBSCRIBE: eNewsletter

Headache and Migraine

The Key to the Case

Test your skills in this case of a woman with severe headache, photophobia, and neck pain. Image: ©Sashkin/Shutterstock read

Blurring the Lines of Migraine Treatment: An In-Depth Interview With Richard B. Lipton, MD

New classes of acute migraine therapies on the cusp of FDA approval look to fill in long-standing gaps in care.

  • READ >>
Migraine brain head pain headache

Fremanezumab Effective in Refractory Episodic and Chronic Migraine

Data from the phase 3b FOCUS trial demonstrates fremanezumab’s superior efficacy and tolerability in the prevention of migraine.

  • READ >>
Migraine brain

Migraine in the United States: Updates in Epidemiology

Epidemiology studies are useful to clinicians because they highlight diagnosis and prescribing patterns, common trends within a disease, and unmet needs.

  • READ >>

Risks of Opioid Use in Migraine Go Beyond Potential Abuse

At the recent American Headache Society meeting, researchers detailed the manifold risks of opioid use in patients with migraine.

  • READ >>

6 New Developments in Migraine

July 8, 2019
  • Leo Robert

Food insecurity and migraine, anxiety sensitivity and migraine severity, supraorbital stimulation to prevent chronic migraine—find summaries of these and other recent findings here.

  • VIEW NOW >>

Migraine and Stroke: Is There a Connection?

July 8, 2019
  • Veronica Hackethal, MD

Physicians should ask patients about their history of headaches and monitor for possible indicators of stroke, especially among older individuals who are already at increased risk.

  • READ >>

Emerging Topics in Neurology

June 14, 2019
  • Heidi Moawad, MD

Discussed in this video: Several novel modalities centered around migraine treatment and prevention.

  • VIEW NOW >>
FDA approval stamp

FDA Gives Nod to New Treatment for Episodic Cluster Headache

June 7, 2019
  • Neurology Times Staff

Emgality (galcanezumab-gnlm) is the first FDA-approved drug that reduces the frequency of headache attacks.

  • READ >>

Green Light Therapy and Migraines: Will Research Translate to Real-World Use?

May 30, 2019
  • Heidi Moawad, MD

A new tool to add to your armamentarium?

  • READ >>

Migraine Matters

May 29, 2019
  • Leo Robert

To kick off Migraine and Headache Awareness Month, the latest findings reported here may influence your approaches to diagnosis, treatment, and prevention and help you keep your patients informed.

  • VIEW NOW >>
Browse more articles

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Headache and Migraine
  • Epilepsy
  • TBI
  • Epilepsy and Seizure
  • Alzheimer disease
There is currently no available content. Please check back soon.
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".